Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
12/2014
12/10/2014CN102272263B 有机光电装置用新化合物和包括该化合物的有机光电装置 The organic photoelectric device including the novel compound and an organic photoelectric device of the compound
12/10/2014CN101506168B 具有快速皮肤穿透速度的带正电荷的水溶性的芳基邻氨基苯甲酸的前药 With a fast rate of penetration of the skin of positively charged water-soluble aryl anthranilic acid prodrug
12/09/2014US8907099 Nitrocatechol derivatives as COMT inhibitors
12/09/2014US8906937 Flavivirus inhibitors and methods of their use
12/02/2014US8901306 Methods and compositions useful in treating cancer and reducing Wnt mediated effects in a cell
12/02/2014US8901303 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
12/02/2014US8901130 Low hygroscopic aripiprazole drug substance and processes for the preparation
12/02/2014US8901129 Methods of facilitating neural cell survival using GDNF family ligand (GFL) mimetics or RET signaling pathway activators
12/02/2014US8901119 Peptide deformylase inhibitors
11/2014
11/27/2014US20140350262 Reactivators Of Organophosphorous Inhibited Acetylcholinesterase
11/27/2014US20140350254 Heterocyclic Compounds for the Treatment of Neurological and Psychological Disorders
11/27/2014US20140350048 Compounds, compositions and associated methods comprising 3-aryl quinolines
11/27/2014US20140350045 Phenoxyisobutyric acid compounds and method of synthesis
11/25/2014US8895572 Fused heterocyclic indane carboxamide CGRP receptor antagonists
11/20/2014US20140343277 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
11/20/2014US20140343096 Deuterated n-ethyl-n-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof
11/20/2014US20140343091 Beta2-adrenoceptor agonists
11/18/2014US8889872 Bisazole-based compound and group VIII transition metal complex
11/18/2014US8889863 Stereoselective methods, catalysts and intermediates for the synthesis of (−)-Nutlin-3 and related compounds
11/18/2014US8889689 Bifunctional metnase/intnase inhibitors and related compositions and methods of treatment of cancer
11/13/2014US20140336378 Novel benzamide derivative and use thereof
11/13/2014US20140336221 Antibiotic and Anti-Parasitic Agents that Modulate Class II Fructose 1, 6-Bisphosphate Aldolase
11/13/2014US20140336219 Pharmaceutical Compositions and Administrations Thereof
11/13/2014US20140336191 Quinolinyloxyphenylsulfonamides
11/13/2014US20140336178 Compositions and methods for modulating interaction between polypeptides
11/13/2014US20140335019 Compositions and methods for the treatment and analysis of neurological disorders
11/11/2014US8884022 Inhibition of bacterial biofilms with aryl carbamates
11/11/2014US8883962 Zinc-responsive peptides, and methods of use thereof
11/11/2014US8883826 Alkynyl derivatives as modulators of metabotropic glutamate receptors
11/11/2014US8883790 Pharmaceutical combinations
11/11/2014US8883786 Glucocorticoid receptor antagonists
11/11/2014US8883766 Ion channel modulators and methods of use
11/11/2014US8883763 Use of isoquinolones for preparing drugs, novel isoquinolones and method for synthesising same
11/11/2014US8883206 Pharmaceutical composition and administrations thereof
11/06/2014US20140329856 Method of treating pain
11/06/2014US20140329855 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
11/06/2014US20140329854 Novel heterocyclic compounds useful in sirtuin binding and modulation
11/06/2014US20140329830 2-carboxamide-4-piperazinyl-benzofuran derivative
11/06/2014US20140329821 Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors
11/04/2014US8877934 N-heteroaryl compounds
11/04/2014US8877931 Process and intermediates for preparing integrase inhibitors
11/04/2014US8877930 Continuous flow synthesis of amino alcohols using microreactors
11/04/2014US8877784 TRPA1 antagonists
11/04/2014US8877776 (L)-malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
11/04/2014US8877775 Substituted 2-aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C
11/04/2014US8877774 Compounds having muscarinic receptor antagonist and beta2 Adrenergic receptor agonist activity
11/04/2014US8877752 4(1H)-quinolones having antimalarial activity with reduced chemical resistance
10/2014
10/30/2014US20140323521 Pharmaceutical compositions and administrations thereof
10/30/2014US20140323520 Compositions and Methods for Increasing Proliferation of Adult Salivary Stem Cells
10/30/2014US20140323518 Novel estrogen receptor ligands
10/30/2014US20140323475 Ep1 receptor ligands
10/30/2014US20140323467 Therapeutic compounds and compositions
10/30/2014US20140323302 Process for the preparation of a quinoline carboxylic acid
10/30/2014US20140322812 Mutant Receptors and Their Use in a Nuclear Receptor-Based Inducible Gene Expression System
10/30/2014US20140322334 Oral solid preparation comprising aripiprazole and method for producing oral solid preparation comprising aripiprazole
10/28/2014US8872422 Dinaphthyl ethylene derivativce, process for preparing it, film prepared from it, and OLED including the film
10/28/2014US8871941 8-bromo-5-quinolinecarboxaldehyde oxime
10/28/2014US8871940 Unsymmetrical bisazides for chemoselective sequential ligation
10/28/2014US8871937 8-hydroxy-quinoline derivatives
10/28/2014US8871936 Method for manufacturing of quinoline-3-carboxamides
10/28/2014US8871789 Method of preventing or treating viral infection
10/23/2014US20140315947 Pharmaceutical composition with enhanced efficacy for inhibiting angiogenesis
10/23/2014US20140315944 Substituted naphthyridine and quinoline compounds as mao inhibitors
10/23/2014US20140315857 N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics
10/21/2014US8865918 Androgen receptor modulator compounds and methods
10/21/2014US8865904 Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use
10/21/2014US8865903 Continuous process for the alkylation of cyclic tertiary amines
10/21/2014US8865902 Deuterated CFTR potentiators
10/21/2014US8865742 Intermediate compounds and processes for the preparation of quinoline derivatives such as Laquinimod sodium
10/21/2014US8865739 Substituted heterocyclic compounds as ion channel modulators
10/21/2014US8865737 Antitumor agent for undifferentiated gastric cancer
10/21/2014US8865736 Antibacterial agents
10/21/2014US8865720 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/16/2014US20140309257 Topoisomerase inhibitors and methods of making and use as therapeutic agents
10/16/2014US20140309236 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
10/16/2014US20140309190 Bicyclic aryl sphingosine 1-phosphate analogs
10/16/2014US20140309180 Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
10/14/2014US8859599 Androgen receptor modulating compounds, preparation and uses thereof
10/14/2014US8859587 (2E)-3-phenyl-N-[2,2,2-Trifluoro-1-[[8-quinolineamino)thiomethyl]amino]ethyl]-2-acrylamide and pharmaceutical uses thereof
10/14/2014US8859584 TRPV1 antagonists
10/09/2014WO2014163622A1 Multifunctional quinoline derivatives as anti-neurodegenerative agents
10/09/2014WO2014163301A1 Method for purifying quinolinic acid
10/09/2014US20140303205 Modulators of cystic fibrosis transmembrane conductance regulator
10/09/2014US20140303203 Compounds for treating peripheral; neuropathies and other neurodegenerative; disorders
10/09/2014US20140301976 Novel hydroxamates as therapeutic agents
10/08/2014EP2786986A2 Novel benzamide derivative and use thereof
10/08/2014EP2785694A1 N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics
10/08/2014EP2785181A1 2-(substituted-phenyl)-cyclopentane-1,3-dione compounds, and derivatives thereof
10/07/2014US8853429 Process and intermediate compounds useful in the preparation of statins
10/07/2014US8853405 Crystalline forms of pitavastatin calcium
10/07/2014US8853258 C-linked hydroxamic acid derivatives useful as antibacterial agents
10/07/2014US8853242 Nitrogenous-ring acylguanidine derivative
10/07/2014US8852756 Materials for organic electroluminescent devices
10/02/2014WO2014158916A1 Substituted naphthyridine and quinoline compounds as mao inhibitors
10/02/2014WO2014158654A1 Ship1 modulators and methods related thereto
10/02/2014WO2014154857A1 Amine salts of pitavastatin and rosuvastatin
10/02/2014WO2014154856A1 Amine salts of pravastatin and rosuvastatin
10/02/2014WO2014154845A1 Pharmaceutically acceptable amine salts of pitavastatin
10/02/2014WO2014154841A1 Process for the manufacture of (r)-5-[2-(5,6-diethylindan-2-ylamino)-1-hydroxyethyl]-8-hydroxy-(1h)-quinolin-2-one
10/02/2014US20140296529 Bis-quinaldine compound and a process for preparing the same
1 2 3 4 5 6 7 8 9 10 11 12 13 ... 277